FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a mouse for producing an immunoglobulin chain, as well as to its cell. Also disclosed is a method for producing the above-mentioned genetically modified mouse containing in its germ line an endogenous immunoglobulin heavy chain locus modified to contain the germ-type kappa (κ) genomic sequence.
EFFECT: resulting mouse can be effectively used to produce a hybrid immunoglobulin binding protein that contains a variable human light chain domain that is functionally linked to the constant region of the heavy chain, to produce an antigen binding protein containing a hybrid immunoglobulin chain and a light chain, and to produce a bispecific antibody.
27 cl, 9 dwg, 5 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
MOUSE PRODUCING BINDING PROTEINS CONTAINING VL-DOMAINS | 2011 |
|
RU2612903C2 |
HUMANIZED GNAWING ANIMALS THAT EXPRESS HEAVY CHAINS CONTAINING V DOMAINS | 2013 |
|
RU2664185C2 |
HUMANIZED RODENTS WHICH EXPRESS HEAVY CHAINS CONTAINING VDOMAINS | 2013 |
|
RU2770016C2 |
HUMANISED LIGHT CHAIN MICE | 2012 |
|
RU2664181C2 |
ANTIBODIES WITH HISTIDINE BUILT IN LIGHT CHAINS AND GENETICALLY MODIFIED ANIMALS DIFFERENT FROM HUMANS FOR THEIR PRODUCTION | 2014 |
|
RU2694728C2 |
MICE EXPRESSING LIMITED REPERTOIRE OF IMMUNOGLOBULIN LIGHT CHAINS | 2014 |
|
RU2812814C2 |
MICE EXPRESSING LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE | 2014 |
|
RU2689664C2 |
MICE WITH HUMANIZED LIGHT CHAIN | 2012 |
|
RU2761639C2 |
RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE | 2012 |
|
RU2603090C2 |
NON-HUMAN ANIMALS WITH MODIFIED SEQUENCES IMMUNOGLOBULIN HEAVY CHAINS | 2014 |
|
RU2618886C2 |
Authors
Dates
2021-06-24—Published
2011-08-02—Filed